Cholangiocarcinoma(CCA)is a particularly aggressive and challenging type of cancer,known for its poor prognosis,which is worsened by the complex interplay of various biological and environmental factors that contribut...
Supported by the Medical Talents of Wuhan Health and Family Planning Commission,No.2017[51](to Yu J);the Medical Talents of Wuhan Hospital of Traditional Chinese and Western Medicine(to Yu J);the Hubei Natural Science Foundation,No.2023AFB1091;Wuhan Medical Research Project,No.WX23A36(to Yu J).
BACKGROUND Cholangiocarcinoma(CCA),also known as bile duct cancer,is a devastating malignancy primarily affecting the biliary tract.AIM To assess their performance in clinical diagnosis and monitoring of CCA,plasma me...
Cholangiocarcinoma(CCA)is a highly aggressive and heterogeneous malignancy arising from the epithelial cells of the biliary tract.The limitations of the current methods in the diagnosis of CCA highlight the urgent nee...
National Natural Science Foundation of China,No.82372194.
BACKGROUND IL-22 plays a pivotal role in the processes of inflammation and tissue healing.,but its role in cholangiocarcinoma(CCA)remains unclear.our study explored the IL-22/IL-22R1 pathway and its impact on CCA prog...
Supported by National Research Foundation of Korea Grant Funded by the Korea Government,No.RS-2023-00213951.
BACKGROUND The cellular prion protein(PrPC),traditionally associated with neurodegenerative disorders,plays an important role in cancer progression and metastasis by inhibiting apoptosis.AIM To investigate the influen...
Supported by the Grants from the National Natural Science Foundation of China(No.82174136);Dalian Medical University Intensified Program of Wellness Interdisciplinary Research Cooperation Project Team Funding(No.JCHZ2023004)。
Cholangiocarcinoma(CCA)is a malignant tumor originating from cholangiocytes.However,it remains unclear about the pathogenesis of this carcinoma,which may be related to multiple factors.Currently,CCA is mainly treated ...
Mixed cholangiocarcinoma is a rare and aggressive neoplastic proliferation of biliary tract epithelial cells,accounting for up to 20%of primary liver cancers.It is the second most common primary liver malignancy with ...
Supported by The National Key Research and Development Program of China,No.2017YFC1308602;The Research Funds by the Fifth Affiliated Hospital of Harbin Medical University,No.2022-002 and No.2023-001.
In this editorial we comment on the article by Tang et al published in the recent issue of World Journal of Hepatology.Drug therapy of intrahepatic cholangiocarcinoma(iCCA)poses an enormous challenge since only a smal...
Supported by The Science and Technology Research Foundation of Guizhou Province,and Zunyi City,No.QKHJC-ZK(2022)YB642,No.ZSKH·HZ(2022)344,and No.gzwjkj2021-071;The WBE Liver Fibrosis Foundation,No.CFHPC2025028;The Beijing Gandan Phase Mutual Public Welfare Fund for Artificial Liver Project,No.iGandanF-1082024-Rgg018.
IgG4-related sclerosing cholangitis(IgG4-SC)is an inflammatory disease that leads to bile duct stricture,characterized by the infiltration of IgG4-positive plasma cells into the bile duct wall,thickening of the bile d...
Cholangiocarcinoma(CCA),a highly aggressive bile duct cancer,is associated with late-stage diagnosis and limited treatment options,leading to poor patient outcomes.Early detection and personalized treatment strategies...